Clinical trials
Not yet recruiting Essential Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boryung Pharmaceutical Co., Ltd | 6 |
| Xuanwu Hospital, Beijing | 2 |
| Abant Izzet Baysal University | 1 |
| Ablative Solutions, Inc. | 1 |
| Assiut University | 1 |
| Cairo University | 1 |
| Evelyn Vanina Re | 1 |
| Instituto Politécnico de Leiria | 1 |
| Jing Huang | 1 |
| Josip Juraj Strossmayer University of Osijek | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 21 |
| Hypertension | 8 |
| Dyslipidemias | 1 |
| Metabolic Diseases | 1 |
| Metabolic Syndrome | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Pediatric Obesity | 1 |
| Prehypertension | 1 |
| Ventricular Dysfunction, Left | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.